Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? Gue YX, Gorog DA, Lip GYH. Circulation 2022;146:1207-1209.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gue YX, Gorog DA, Lip GYH. Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? Circulation 2022;146:1207-1209.
PMID: 36030388